OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans
Authors
Keywords
-
Journal
npj Vaccines
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-12
DOI
10.1038/s41541-023-00651-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic activity of antibodies in the multicomponent 4CMenB vaccine
- (2022) Viola Viviani et al. Expert Review of Vaccines
- Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study
- (2022) Bing Wang et al. LANCET INFECTIOUS DISEASES
- Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
- (2022) Chun-Mien Chang et al. VACCINE
- Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates
- (2021) Benjamin I. Baarda et al. mSphere
- Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
- (2021) Yara Ruiz García et al. npj Vaccines
- Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms
- (2020) Lisa A. Lewis et al. FEBS LETTERS
- Synergic complement‐mediated bactericidal activity of monoclonal antibodies with distinct specificity
- (2020) Eriberto Noel Natali et al. FASEB JOURNAL
- GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
- (2020) Francesca Micoli et al. Vaccines
- The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
- (2020) Isabelle Leduc et al. PLoS Pathogens
- Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis
- (2019) Amaka M. Awanye et al. Scientific Reports
- The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
- (2019) Vega Masignani et al. Frontiers in Immunology
- Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
- (2018) M. Giuliani et al. Scientific Reports
- The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations
- (2018) Reinaldo Acevedo et al. Expert Review of Vaccines
- Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
- (2017) Helen Petousis-Harris et al. LANCET
- The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C
- (2017) Elizabeth Partridge et al. VACCINE
- Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)
- (2016) Ashesh Gandhi et al. POSTGRADUATE MEDICINE
- Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice
- (2015) Eduardo Lujan et al. INFECTION AND IMMUNITY
- Neisseriaproteomics for antigen discovery and vaccine development
- (2014) Myron Christodoulides Expert Review of Proteomics
- Recombinant Neisseria surface protein A is a potential vaccine candidate against Neisseria meningitides serogroup B
- (2014) SHANGYUN YING et al. Molecular Medicine Reports
- Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens
- (2014) Jeannette N. Williams et al. VACCINE
- Quantification by LC–MSE of outer membrane vesicle proteins of the Bexsero® vaccine
- (2014) Chiara Tani et al. VACCINE
- A phase II randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II)
- (2014) Susanna Esposito et al. Human Vaccines & Immunotherapeutics
- Potential of the adhesin complex protein ofNeisseria meningitidisfor next-generation meningococcal vaccines
- (2013) Miao-Chiu Hung et al. Expert Review of Vaccines
- Meningococcal Omp85 in Detergent-Extracted Outer Membrane Vesicle Vaccines Induces High Levels of Non-Functional Antibodies in Mice
- (2013) E. Wedege et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
- (2013) Johan Holst et al. Human Vaccines & Immunotherapeutics
- Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
- (2011) Xilian Bai et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants inNeisseria meningitidisprotein vaccines
- (2011) Holly Sanders et al. Expert Review of Vaccines
- An improved counterselection cassette for use in Haemophilus influenzae
- (2011) Jason W. Johnston GENE
- A Meningococcal Factor H Binding Protein Mutant That Eliminates Factor H Binding Enhances Protective Antibody Responses to Vaccination
- (2011) P. T. Beernink et al. JOURNAL OF IMMUNOLOGY
- Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
- (2011) David M. Vu et al. VACCINE
- A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
- (2011) P.B. Keiser et al. VACCINE
- Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood Survival
- (2011) Hebert Echenique-Rivera et al. PLoS Pathogens
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life
- (2010) Matthew D. Snape et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
- (2010) Davide Serruto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA
- (2010) Paul B. Keiser et al. VACCINE
- Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
- (2010) Marzia M. Giuliani et al. VACCINE
- Towards the Immunoproteome of Neisseria meningitidis
- (2009) Tom A. Mendum et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More